|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shield KD, Ferlay J, Jemal A,
Sankaranarayanan R, Chaturvedi AK, Bray F and Soerjomataram I: The
global incidence of lip, oral cavity, and pharyngeal cancers by
subsite in 2012. CA Cancer J Clin. 67:51–64. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sasahira T and Kirita T: Hallmarks of
cancer-related newly prognostic factors of oral squamous cell
carcinoma. Int J Mol Sci. 19:192018. View Article : Google Scholar
|
|
5
|
de Souza DA Jr, Santana AC, da Silva EZ,
Oliver C and Jamur MC: The role of mast cell specific chymases and
tryptases in tumor angiogenesis. BioMed Res Int.
2015:1423592015.
|
|
6
|
Bauer R, Humphries M, Fässler R,
Winklmeier A, Craig SE and Bosserhoff AK: Regulation of integrin
activity by MIA. J Biol Chem. 281:11669–11677. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Detoraki A, Staiano RI, Granata F,
Giannattasio G, Prevete N, de Paulis A, Ribatti D, Genovese A,
Triggiani M and Marone G: Vascular endothelial growth factors
synthesized by human lung mast cells exert angiogenic effects. J
Allergy Clin Immunol. 123:1142–1149. 11491e1–5. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sammarco G, Varricchi G, Ferraro V,
Ammendola M, De Fazio M, Altomare DF, Luposella M, Maltese L, Currò
G, Marone G, et al: Mast cells, angiogenesis and lymphangiogenesis
in human gastric cancer. Int J Mol Sci. 20:202019. View Article : Google Scholar
|
|
9
|
Jachetti E, Cancila V, Rigoni A,
Bongiovanni L, Cappetti B, Belmonte B, Enriquez C, Casalini P,
Ostano P, Frossi B, et al: Cross-talk between myeloid-derived
suppressor cells and mast cells mediates tumor-specific
immunosuppression in prostate cancer. Cancer Immunol Res.
6:552–565. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nagata M, Shijubo N, Walls AF, Ichimiya S,
Abe S and Sato N: Chymase-positive mast cells in small sized
adenocarcinoma of the lung. Virchows Arch. 443:565–573. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ibaraki T, Muramatsu M, Takai S, Jin D,
Maruyama H, Orino T, Katsumata T and Miyazaki M: The relationship
of tryptase- and chymase-positive mast cells to angiogenesis in
stage I non-small cell lung cancer. Eur J Cardiothorac Surg.
28:617–621. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carlini MJ, Dalurzo MC, Lastiri JM, Smith
DE, Vasallo BC, Puricelli LI and Lauría de Cidre LS: Mast cell
phenotypes and microvessels in non-small cell lung cancer and its
prognostic significance. Hum Pathol. 41:697–705. 2010. View Article : Google Scholar
|
|
13
|
Shikotra A, Ohri CM, Green RH, Waller DA
and Bradding P: Mast cell phenotype, TNFα expression and
degranulation status in non-small cell lung cancer. Sci Rep.
6:383522016. View Article : Google Scholar
|
|
14
|
Kondo K, Muramatsu M, Okamoto Y, Jin D,
Takai S, Tanigawa N and Miyazaki M: Expression of chymase-positive
cells in gastric cancer and its correlation with the angiogenesis.
J Surg Oncol. 93:36–42; discussion 42-43. 2006. View Article : Google Scholar
|
|
15
|
Siiskonen H, Poukka M, Bykachev A,
Tyynelä-Korhonen K, Sironen R, Pasonen-Seppänen S and Harvima IT:
Low numbers of tryptase+ and chymase+ mast cells associated with
reduced survival and advanced tumor stage in melanoma. Melanoma
Res. 25:479–485. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mehdawi L, Osman J, Topi G and Sjölander
A: High tumor mast cell density is associated with longer survival
of colon cancer patients. Acta Oncol. 55:1434–1442. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Glajcar A, Szpor J, Pacek A, Tyrak KE,
Chan F, Streb J, Hodorowicz-Zaniewska D and Okoń K: The
relationship between breast cancer molecular subtypes and mast cell
populations in tumor microenvironment. Virchows Arch. 470:505–515.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stieglitz D, Lamm S, Braig S, Feuerer L,
Kuphal S, Dietrich P, Arndt S, Echtenacher B, Hellerbrand C, Karrer
S, et al: BMP6-induced modulation of the tumor micro-milieu.
Oncogene. 38:609–621. 2019. View Article : Google Scholar
|
|
19
|
Bosserhoff AK: Melanoma inhibitory
activity (MIA): An important molecule in melanoma development and
progression. Pigment Cell Res. 18:411–416. 2005.PubMed/NCBI
|
|
20
|
Kurihara M, Kirita T, Sasahira T, Ohmori
H, Matsushima S, Yamamoto K, Bosserhoff AK and Kuniyasu H:
Protumoral roles of melanoma inhibitory activity 2 in oral squamous
cell carcinoma. Br J Cancer. 108:1460–1469. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sasahira T, Kirita T, Kurihara M, Yamamoto
K, Bhawal UK, Bosserhoff AK and Kuniyasu H: MIA-dependent
angiogenesis and lymphangiogenesis are closely associated with
progression, nodal metastasis and poor prognosis in tongue squamous
cell carcinoma. Eur J Cancer. 46:2285–2294. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sasahira T, Kirita T, Oue N, Bhawal UK,
Yamamoto K, Fujii K, Ohmori H, Luo Y, Yasui W, Bosserhoff AK, et
al: High mobility group box-1-inducible melanoma inhibitory
activity is associated with nodal metastasis and lymphangiogenesis
in oral squamous cell carcinoma. Cancer Sci. 99:1806–1812.
2008.PubMed/NCBI
|
|
23
|
Sasahira T, Kirita T, Yamamoto K, Ueda N,
Kurihara M, Matsushima S, Bhawal UK, Bosserhoff AK and Kuniyasu H:
Transport and Golgi organisation protein 1 is a novel tumour
progressive factor in oral squamous cell carcinoma. Eur J Cancer.
50:2142–2151. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sasahira T, Nishiguchi Y, Fujiwara R,
Kurihara M, Kirita T, Bosserhoff AK and Kuniyasu H: Storkhead box 2
and melanoma inhibitory activity promote oral squamous cell
carcinoma progression. Oncotarget. 7:26751–26764. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
O'Sullivan B: Head and neck tumours. UICC
TNM classification of malignant tumours. Brierley JD, Gospodarowicz
MK and Wittekind C: 8th edition. Wiley; Chichester: pp. 17–54.
2017
|
|
26
|
Sloan P, Gale N, Hunter K, Lingen M,
Nylander K, Reibel J, Salo T and Zain RB: Malignant surface
epithelial tumors. WHO classification of head and neck tumors.
El-Naggar AK, Chan JKC, Grandis JR, et al: 4th edition. IARC Press;
Lyon: pp. 17–54. 2017
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
28
|
Iamaroon A, Pongsiriwet S, Jittidecharaks
S, Pattanaporn K, Prapayasatok S and Wanachantararak S: Increase of
mast cells and tumor angiogenesis in oral squamous cell carcinoma.
J Oral Pathol Med. 32:195–199. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mohtasham N, Babakoohi S, Salehinejad J,
Montaser-Kouhsari L, Shakeri MT, Shojaee S, Sistani NS and Firooz
A: Mast cell density and angiogenesis in oral dysplastic epithelium
and low- and high-grade oral squamous cell carcinoma. Acta Odontol
Scand. 68:300–304. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yadav A, Desai RS, Bhuta BA, Singh JS,
Mehta R and Nehete AP: Altered immunohistochemical expression of
mast cell tryptase and chymase in the pathogenesis of oral
submucous fibrosis and malignant transformation of the overlying
epithelium. PLoS One. 9:e987192014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Oliveira-Neto HH, Leite AF, Costa NL,
Alencar RC, Lara VS, Silva TA, Leles CR, Mendonça FE and Batista
AC: Decrease in mast cells in oral squamous cell carcinoma:
Possible failure in the migration of these cells. Oral Oncol.
43:484–490. 2007. View Article : Google Scholar
|
|
32
|
Sugimoto M, Furuta T, Kodaira C, Nishino
M, Yamade M, Ikuma M, Sugimura H and Hishida A: Polymorphisms of
matrix metalloproteinase-7 and chymase are associated with
susceptibility to and progression of gastric cancer in Japan. J
Gastroenterol. 43:751–761. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sugimoto M, Furuta T, Shirai N, Ikuma M,
Sugimura H and Hishida A: Influences of chymase and angiotensin
I-converting enzyme gene polymorphisms on gastric cancer risks in
Japan. Cancer Epidemiol Biomarkers Prev. 15:1929–1934. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Raica M, Cimpean AM, Popovici RA, Balica
AR, Vladau M and Gaje PN: Mast cells stimulate lymphangiogenesis in
the gingiva of patients with periodontal disease. In Vivo.
29:29–34. 2015.PubMed/NCBI
|
|
35
|
Jiang Y, Wu Y, Hardie WJ and Zhou X: Mast
cell chymase affects the proliferation and metastasis of lung
carcinoma cells in vitro. Oncol Lett. 14:3193–3198. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rolli M, Fransvea E, Pilch J, Saven A and
Felding-Habermann B: Activated integrin alphavbeta3 cooperates with
metallopro-teinase MMP-9 in regulating migration of metastatic
breast cancer cells. Proc Natl Acad Sci USA. 100:9482–9487. 2003.
View Article : Google Scholar
|
|
37
|
Dyduch G, Kaczmarczyk K and Okoń K: Mast
cells and cancer: Enemies or allies? Pol J Pathol. 63:1–7.
2012.PubMed/NCBI
|
|
38
|
Jachimczak P, Apfel R, Bosserhoff AK,
Fabel K, Hau P, Tschertner I, Wise P, Schlingensiepen KH,
Schuler-Thurner B and Bogdahn U: Inhibition of immunosuppressive
effects of melanoma-inhibiting activity (MIA) by antisense
techniques. Int J Cancer. 113:88–92. 2005. View Article : Google Scholar
|
|
39
|
Pfeufer A, Osterziel KJ, Urata H, Borck G,
Schuster H, Wienker T, Dietz R and Luft FC: Angiotensin-converting
enzyme and heart chymase gene polymorphisms in hypertrophic
cardiomyopathy. Am J Cardiol. 78:362–364. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shimomoto T, Ohmori H, Luo Y, Chihara Y,
Denda A, Sasahira T, Tatsumoto N, Fujii K and Kuniyasu H:
Diabetes-associated angiotensin activation enhances liver
metastasis of colon cancer. Clin Exp Metastasis. 29:915–925. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bowrey PF, King J, Magarey C, Schwartz P,
Marr P, Bolton E and Morris DL: Histamine, mast cells and tumour
cell proliferation in breast cancer: Does preoperative cimetidine
administration have an effect? Br J Cancer. 82:167–170. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang FC, Ingram DA, Chen S, Zhu Y, Yuan J,
Li X, Yang X, Knowles S, Horn W, Li Y, et al: Nf1-dependent tumors
require a microenvironment containing Nf1+/−- and
c-kit-dependent bone marrow. Cell. 135:437–448. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pittoni P, Piconese S, Tripodo C and
Colombo MP: Tumor-intrinsic and -extrinsic roles of c-Kit: Mast
cells as the primary off-target of tyrosine kinase inhibitors.
Oncogene. 30:757–769. 2011. View Article : Google Scholar
|
